Study of Sorafenib and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma
| Status: | Archived |
|---|---|
| Conditions: | Liver Cancer, Cancer, Gastrointestinal |
| Therapuetic Areas: | Gastroenterology, Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | February 2009 |
| End Date: | February 2013 |
Phase II Trial of Sorafenib Combined With Doxorubicin Eluting Bead-Transarterial Chemoembolization (LC Bead-TACE) for Patients With Hepatocellular Carcinoma
This study will combine two therapies to treat patients with unresectable hepatocellular
carcinoma; sorafenib, and drug eluting beads delivered intra-arterially. The purpose of
the study is to establish the safety and the effectiveness of the combination therapy. The
investigators hypothesize that the combination of the two therapies will not result in
greater toxicities to patients than that expected for either therapy given alone.
We found this trial at
1
site
Johns Hopkins Hosp From the 1889 opening of The Johns Hopkins Hospital, to the opening...
Click here to add this to my saved trials
